Skip to main content
. 2013 Nov 22;8(11):e80982. doi: 10.1371/journal.pone.0080982

Table 9. Clinical data from celiac patients on a gluten-free diet (n=17) from the pediatric population (n=48).

Sample Sex   Age  HLA DQ2/DQ8    IgA anti-tTG   IgA anti-DGP 8-mer Atrophy grade at diagnosis (Marsh criteria)   Months on GFD
GFD-32 F 10 + - + III N.R
GFD-33 F 7 + + + III 4
GFD-34 F 6 + - - III 4
GFD-35 F 2 + + - N.D 1.5
GFD-36 M 4 + + - III 3
GFD-37 F 2 + - - N.D 6
GFD-38 F 3 + + - III 3
GFD-39 M 4 + + - III 4
GFD-40 F 2 + - - N.D 10
GFD-41 F 2 + - - N.D 6
GFD-42 M 5 + + - III 3
GFD-43 M 2 + - - III 2
GFD-44 F 3 + + - II 3
GFD-45 M 1 + + - III 12
GFD-46 M 12 + + - N.D 5
GFD-47 F 11 + + - N.D 7
GFD-48 M 2 + + - N.D 1

Table shows the following information: sex (M: male and F: female), age (from 1 to 12 years), HLA DQ2/DQ8, IgA anti-tTG, IgA anti-DGP 8-mer and Marsh scale of the severity of lesion at diagnosis (from Marsh I to Marsh III). N.D (Not determined) and M.M (mild mucosal alterations). The time on GFD is shown in months, except one patient who did not response to the GFD (N.R).